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Abstract
Huntington’s disease (HD) is caused by the expansion of a CAG repeat in the huntingtin (HTT) gene. The R6 mouse
models of HD express a mutant version of exon 1 HTT and typically develop motor and cognitive impairments, a
widespread huntingtin (HTT) aggregate pathology and brain atrophy. Unlike the more commonly used R6/2 mouse
line, R6/1 mice have fewer CAG repeats and, subsequently, a less rapid pathological decline. Compared to the R6/2
line, fewer descriptions of the progressive pathologies exhibited by R6/1 mice exist. The association between the
molecular and cellular neuropathology with brain atrophy, and with the development of behavioral phenotypes
remains poorly understood in many models of HD. In attempt to link these factors in the R6/1 mouse line, we have
performed detailed assessments of behavior and of regional brain abnormalities determined through longitudinal, in
vivo magnetic resonance imaging (MRI), as well as an end-stage, ex vivo MRI study and histological assessment.
We found progressive decline in both motor and non-motor related behavioral tasks in R6/1 mice, first evident at 11
weeks of age. Regional brain volumes were generally unaffected at 9 weeks, but by 17 weeks there was significant
grey matter atrophy. This age-related brain volume loss was validated using a more precise, semi-automated Tensor
Based morphometry assessment. As well as these clear progressive phenotypes, mutant HTT (mHTT) protein, the
hallmark of HD molecular pathology, was widely distributed throughout the R6/1 brain and was accompanied by
neuronal loss. Despite these seemingly concomitant, robust pathological phenotypes, there appeared to be little
correlation between the three main outcome measures: behavioral performance, MRI-detected brain atrophy and
histopathology. In conclusion, R6/1 mice exhibit many features of HD, but the underlying mechanisms driving these
clear behavioral disturbances and the brain volume loss, still remain unclear.
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Introduction
Huntington’s disease (HD), a progressive, autosomal
dominant neurological disorder, is caused by a CAG/
polyglutamine repeat expansion [1]. This unstable elongation
leads to the eventual aggregation of mutant huntingtin (mHTT),
resulting in neurodegeneration and ultimately death. Even
during the prodromal phase, subtle brain changes have been
shown to be associated with disease burden [2,3,4]. Still,
despite the genetic cause for HD being identified, the causal
cascade linking the activity of mHTT with the development of
clinical signs remains poorly understood. The varying nature of
HD, as well as the scarcity of affected tissue during the early
stages of disease, impede efforts to link molecular pathology to
both brain atrophy and motor/behavioral dysfunction.
To overcome such issues and improve our understanding of
the causes of HD, a variety of rodent models have been
developed. Transgenic mice include the R6 [5] and N171Q82
[6] lines that express N-terminal fragments of HTT, as well as
the YAC128 [7] and BACHD [8] lines that express a mutant
version of the full-length protein. The genetic basis of HD is
more precisely recapitulated by the knock-in models in which
an expanded CAG repeat has been inserted into mouse Htt
and that develop a more slowly progressing phenotype
[9,10,11]. There are several comparable late-stage phenotypes
between R6/2 mice at 12-14 weeks and HdhQ150 mice at 22
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months of age [12,13,14,15,16]. Consequently, we defined the
N-terminal mHTT fragments that are present in HdhQ150 brain
tissue and found that the smallest fragment is exon 1 protein
[17]. We have subsequently shown that this is generated
through the mis-splicing of exon 1, indicating that the R6 mice
are a model for the aberrant splicing that occurs in HD [18].
This current study is part of a continuing detailed comparison of
the progressive pathologies exhibited by the R6 and knock-in
mouse models.
We have previously described the concomitant behavioral
dysfunction and development of brain abnormalities detected
through magnetic resonance imaging (MRI) exhibited by the
R6/2 mouse line, expressing ~210 CAG repeats [19]. A similar,
but lesser used mouse model, the R6/1 line, expresses fewer
CAG repeats (typically ~110-120) and consequently exhibit a
slower pathological progression and elongated life-span,
compared to R6/2, up to 40 weeks [5]. These features
potentially make it more suitable and sensitive to investigate
early molecular changes and their relevance to behavioral
impairments. R6/1 mice exhibit age-related progressive
impairments at both motor and cognitive tests from as early as
2 months of age [20], and age related neuronal loss, brain
atrophy and mHTT accumulation [21].
Recent efforts have been made to characterize disease
burden in HD mouse models, including transgenic [20,21],
BACHD [22], YAC128 [23,24,25,26], as well as the CAG
knock-in mice of varying repeat lengths
[27,28,29,30,31,32,33,34,35]. Such descriptions of pathological
progression are essential for understanding how the
construction of an HD mouse can lead to varying phenotypes.
Nevertheless, establishing a causal relationship requires a
longitudinal assessment of the emergence of behavioral
dysfunction with concomitant measurement of brain atrophy by
MRI, along with their correlation with cellular and molecular
changes. We here present a correlative analysis of these
concomitant changes in behavior and pathology in both female
and male R6/1 mice.
Materials and Methods
Ethics statement
All experimental procedures performed on mice were
approved by the King’s College London Ethical Review
Process Committee and carried out under Home Office License
70/6445.
Animals
Hemizygous R6/1 mice were bred by backcrossing R6/1
males to (CBA x C57BL/6) F1 females (B6CBAF1/OlaHsd,
Harlan Olac, Bicester, UK). Mice were genotyped and the CAG
repeat size was measured, as described previously [15]. The
CAG repeat was 123.19 (± 1.52, SD); the CAG repeat length
did not differ between male (123.33 ± 0.866, SD) and female
(123.0 ± 2.16) R6/1 mice. Littermates were divided into four
groups: male wild type (WT, n= 11), male R6/1 (n=9), female
WT (n=10) and female R6/1 (n=10), an equal ratio between
male:female was aimed for. For exact numbers of subjects
included at each stage of analysis see Table S1. All
procedures reported here (behavioral, MRI and histological)
were conducted on the same cohort of animals.
WT and R6/1 mice were housed under standard animal
laboratory conditions. Room temperature was automatically
maintained at 21°C ± 1°C. Animals were kept on a 12h
light:dark cycle. Mice were group-housed dependent on
gender, but genotypes were mixed within the cages. All mice
had access to standard cage environmental enrichment
(bedding and play tube) and maintained on a standard chow
diet with tap water available ad libitum. Body weight was
monitored at 6, 10, 14, 18 and 19 weeks of age. Body
temperature was recorded up to 18 weeks of age through an
infra-red temperature reader (ThermoScan Instant
Thermometer, Braun) reproducibly positioned under the thorax.
An overview of the experimental design is presented in Figure
1A.
Behavioral tests
Mice were exposed to repeated behavioral testing from 6
weeks of age (Figure 1A). Learning in a swimming T-maze was
probed at both 6 and 15 weeks of age (~2 week procedure at
both ages). Grip strength capacity and behaviors exhibited in
an open field were tested twice, at 10 and 19 weeks. Olfactory
capacity and discrimination of social novelty were investigated
at 10 weeks only, and motor coordination and cognition were
tested in the rotarod and fear conditioning paradigms at 11 and
12 weeks respectively.
Motor-related tasks
Rotarod.  Motor coordination was tested on an accelerating
rotarod at 11 weeks of age, as described previously [19]. In
brief, mice were individually placed on an accelerating, rotating
beam (4-40 rpm) for a maximum of 300 sec. Latency to fall
from the beam (sec) was recorded as a measure of motor
performance. Mice were exposed to three trials per day for four
consecutive days (day 1 behavior was considered habituation
to the test and the data was subsequently discarded). The
whole apparatus was thoroughly cleaned with 70% industrial
methylated spirit (IMS) between trials.
Open field.  General ambulation was probed in an open-field
arena at 10 and 19 weeks of age. The test was conducted 2 h
into the mouse’s dark cycle, under red-light conditions. Mice
were habituated to the test room conditions for 2 h, then
individually placed into square, plain white arenas (50 x 50 x 50
cm, Engineering & Design Plastics Ltd., Cambridge, UK) for 30
min, and behavior was recorded through a video camera
positioned above the apparatus. Activity (distance moved, cm)
was tracked and later analyzed using EthoVision 7XT software
(Noldus, Netherlands). Arenas were thoroughly cleaned with
70% IMS between trials.
Grip strength.  Grip strength capacity was assessed at both
10 and 19 weeks of age. The protocol allowed for the
independent measurement of the strength of the forelimbs only,
as well as fore- and hind limbs taken together. Mice were held
by the base of the tail and gently swung to allow them to grip
the wire-mesh grid attached to a grip strength monitor (Bioseb
In Vivo Research Instruments). Mice were either allowed to grip
with forelimbs, or fore- and hind limbs together, and then gently
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pulled away from the apparatus. Maximum tension (g) before
the mouse released the grid was recorded. For both grip
strength recordings (forelimb only, and fore- and hind limbs
together), the mice were given three attempts and the average
performance was taken for analysis.
Non-motor-related tasks
Swimming T-maze.  Cue learning, and the reversal of cue
learning was conducted in a swimming T-maze at 6 and 15
weeks of age, using an adapted protocol [24]. The maze
consisted of a start corridor (122 cm length, 12 cm width, 35
cm depth made from black, opaque plastic) leading to a left
and right choice arm (60 cm length, 12 cm width, 35 cm depth)
forming a T-junction. The maze was filled with water made
opaque through the addition of a whitening agent (Marvel dried
skimmed milk, Premier Foods, UK). Water was replaced and
the maze thoroughly cleaned every third day. A transparent
plastic square escape platform was submerged 0.5 cm,
invisible under the water surface. Water temperature was
maintained at 21-25°C throughout the duration of the
procedure. For “cue learning”, the escape platform was
pseudo-randomly located (location order picked randomly out-
of-a-hat), at either the left or right end of the top arm and was
cued to the presence of an illuminated desktop lamp directly
over the escape platform. Mice were individually placed in the
starting position (at the base of the starting arm, opposite
where it bisects the top arm) and allowed to swim to the T-
junction of the two arms whereupon it made a decision to swim
either toward the light (where it reached the escape platform
and was removed from the maze), or away from the light
Figure 1.  Experimental design and body weight measures.  (A) Experimental design from 6 to 19 weeks of age. All mice were
subjected to repeated assessments of behaviors, alongside in vivo MRI taken at 9 and 17 weeks of age. At 19 weeks of age all mice
were culled and an ex vivo MRI scan was taken. STM = swimming T-maze; GS = grip strength; OF = locomotor activity in an open
field, OD = odor discrimination, SI = social interaction, RR = rotarod, FC = cued and contextual fear conditioning. Body weight gain
for both male (B) and female mice (C). Body weight analyzed using three-way ANOVA (Genotype X Gender X Age). Body weight:
WT male n=11, R6/1 male n=9, WT female n=10, R6/1 female n=10-8. All data presented as means ± SEM; *p<0.05.
doi: 10.1371/journal.pone.0084726.g001
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(where it was forced to remain in the incorrect arm for 10 sec
before being allowed to enter the correct side of the top arm
and find the escape platform). Mice were towel dried between
trials. Mice were exposed to 12 trails per day until they reached
criterion (10 correct choices out of 12 successive trials
(including rolling over from the previous day), 83.3% correct
rate), whereby they began the second part of the trial, termed
“cue reversal” learning. For cue reversal training, mice were
exposed to the same conditions to those described for the first,
cued learning part of the task, but the desktop lamp cue was
now situated at the opposite arm to escape platform. Thus,
mice were forced to re-learn the escape conditions. Cue
reversal training was run until mice reached criterion (again,
83.3% correct rate), at which point the assessment was
discontinued.
Fear conditioning.  Cued and contextual fear conditioning
was used to probe cognitive function in these mice at 12
weeks, using an adapted protocol [36]. Experiments were
conducted using a standard fear conditioning system (TSE-
Systems, Germany). The test was divided into three days, day
1 “training”, day 2 “cue recall and extinction” and day 3 “context
recall”.
Day 1 “training”.  The operant chamber was scented using
a solution of 79.5% water, 19.5% ethanol, 1% vanilla extract.
Mice were individually placed in the arenas and exposed to the
conditioning protocol; three pairings of a conditioned stimulus
(30 sec auditory tone), and an unconditioned stimulus foot-
shock (0.5mA, 1 sec duration).
Day 2 “cue recall and extinction”.  The operant chamber
was thoroughly cleaned with 50% ethanol to remove all vanilla
extract odor. Monochrome patterned wall inserts and a plain
white floor insert were added to change the context of the
operant chamber. Mice were individually placed in the chamber
and subjected to 25 exposures of the conditioned stimulus
(auditory tone), but no foot shock, in order to measure cued
recall and extinction of conditioned fear.
Day 3 “context recall”.  The operant chamber was returned
to the identical context as described for Day 1 (chamber inserts
removed, and vanilla odor added) with mice being placed in the
operant chamber for 5 min with no conditioned or
unconditioned stimuli to determine contextual recall of
conditioned fear.
Throughout the duration of these tests, behavior was
videotaped by a camera positioned above the apparatus.
Mouse immobility (a complete absence of movement except
breathing) was considered a measure of fear, scored by an
investigator blinded to the experimental groupings. An inter-
rater reliability of >95% confidence was achieved. For cued
recall and extinction on Day 2, immobility over five summed CS
exposures (giving a total of 5, 30 sec blocks) was used for
analysis. For contextual recall on Day 3, immobility was
expressed over the entire 5 min trial.
Odor discrimination.  This test was conducted to probe
olfactory function of mice at 10 and 19 weeks of age. Mice
were habituated to plain white arenas (50 x 50 x 50 cm), for 10
min per day for two days prior to starting the test. On the test
day, two samples of mouse litter were available for
investigation over a total of 5 min, one sample being clean
litter, the other being soiled litter from unfamiliar sex-matched
mice. Samples of litter were held in up-turned eppendorf tubes
with 0.5 cm of the tips removed to allow the animal to smell the
contents. Behavior was video taped from above and
subsequently analyzed. Time spent investigating the tubes
(nose pokes directly at the aperture of the tubes) was
quantified by an investigator blinded to both the samples and
experimental groupings. Preference for the soiled litter was
expressed as percentage of time investigating soiled sample
out of total time investigating either sample. An inter-rater
reliability of >95% was achieved. Arenas were thoroughly
cleaned with 70% IMS between trials.
Social interaction.  Social behaviors, as well as the ability to
discriminate novelty, was tested at 10 weeks of age using an
adapted protocol [37]. Test mice were habituated to plain white
arenas (50 x 50 x 50 cm) for 1 h. Two corrals (up-turned pen
holders, Staples, UK) were then positioned inside the arenas in
reproducible positions, and the test mice were allowed to
habituate to the corrals for a further 30 min. During “exposure
1”, a sex-matched, 8 week old C57Bl/6 mouse was positioned
in one corral and the test mouse was allowed to investigate,
but not physically interact with the mouse for 5 min. This now
“familiar” mouse was removed, and following an inter-trial-
interval of 30 min “exposure 2” was conducted, whereby the
“familiar” mouse was replaced back into the same corral and a
different, “novel” C57Bl/6 mouse was placed in the other corral,
the test mouse was free to investigate either the familiar or
novel mouse. Behavior was video-taped from above and
subsequently analyzed. Time spent investigating the familiar
and/or novel mice was measured by an investigator blinded to
the experimental groups. An inter-rater reliability of >95% was
achieved. Arenas and corrals were thoroughly cleaned with
70% IMS between trials.
Magnetic Resonance Imaging
In vivo longitudinal MRI.  WT and R6/1 mice were scanned
twice in vivo, at 9 and 17 weeks of age. Mice were
anaesthetized using 5% isoflurane along with a combination of
medical air (0.7 l/min) and oxygen (0.3 l/min). Once fully
anesthetized, mice were positioned and fixed into a plastic
frame, where anesthetic was administered through a facemask.
Mice were maintained under anesthesia, typically between
1-2% isoflurane for the duration of the scanning. Temperature
was maintained through a homeostatic heating airflow system
and breathing rate monitored through a respiration balloon
positioned under the thorax (Small Animal Instruments, New
York, USA). Post scanning, but prior to recovery, mice were
administered 0.1ml saline i.p. to abate dehydration.
Images were acquired on a 7T horizontal bore Magnetic
Resonance Imaging (MRI) system (Varian, Paolo Alto,
California, USA), with a 100 Gauss gradient set insert and a 39
mm-bore (transmission and receiver) radiofrequency coil
(Rapid, Germany). The scanner was controlled through VnmrJ
software (Varian, Paolo Alto, California, USA). Correct
positioning of the mouse within the RF coil was confirmed
through a series of scouting images. A Multi-Echo-Multi-Slice
(MEMS) scan was then acquired (TR = 2500 msec, TE = 10
msec, echo train = 8, averages = 4, matrix = 128 x 128, FOV =
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20 x 20 mm, 30 coronal slices at 0.5 mm thickness, 21 min
acquisition time). The typical signal-to-noise ratio (SNR) = 5.4,
the typical white:grey matter ratio (WGR) = 1.25. Coronal slices
were positioned based on a reproducible anatomical marker
(the most visibly posterior part of the cerebellum).
Post-acquisition, all eight echoes were summed into a single
structural image set. As previously described, [19,38], these
images were used to manually delineate neuroanatomical
structures in JIM Ver. 5.0 (Xinapse Systems, Alwincle, UK).
Regions-of-interest (ROIs) consisted of: whole brain, cortex,
striatum, hippocampus, and corpus callosum. ROIs were
delineated by two investigators blinded to the experimental
groupings, and intra- and inter-rater reliability was consistently
≥ 95% confidence. Details of neuroanatomical inclusion criteria
and delineation guidelines were identical to those described
previously [19]. All information outside of the ROIs was
subsequently masked out, the ROIs were then individually
saved in NIFTI format. Volumetric data were calculated and
processed semi-automatically using Python Ver.2.6 (Python
Software Foundation). To measure changes in T2 relaxivity
(reflective of tissue composition), maps of T2 signal intensity
were obtained through a mono-exponential fit of the eight
echoes. The ROIs were superimposed onto the maps of T2
signal intensity allowing for the generation of mean T2
relaxation times within each ROI. A small circular ROI was
taken for cheek muscle tissue T2 relaxivity in order to act as an
internal control measure.
Ex vivo MRI.  Post-mortem ex vivo MRI scans were taken at
a higher-resolution compared to the in vivo scans and did not
suffer from potential artefacts arising in live scanning (e.g. head
movement). A more precise measurement of subtle changes in
brain structures is therefore achievable. Following the final
behavior test, at 19 weeks of age, mice were anaesthetized
using terminal anesthesia (Euthatal, Marial, Harlow, UK), and
then transcardially perfused with heparinized saline (50 units/
ml), followed by Parafix (4% paraformaldehyde, Pioneer
Research Chemical Ltd., Essex, UK). Whole heads were
removed and submerged in Parafix and kept at 4°C until ex
vivo imaging. The scanning set-up was identical to that used
for in vivo imaging. Correct positioning of the mouse head
within the RF coil was confirmed through a series of scouting
images. An MEMS sequence was then acquired (TR = 3000
msec, TE = 10 msec, echo train = 8, averages = 22, matrix =
192 x 192, FOV = 19.2 x 19.2 mm, 35 coronal slices at 0.5 mm
thickness, acquisition time for scan was ~3.5 hours). Typical
SNR = 11.96, typical WGR = 1.54. Resulting images were
subsequently converted to ANALYZE 7.5 for Tensor Based
Morphometry (TBM).
Tensor Based Morphometry.  An un-biased whole-brain
comparison of WT and R6/1 at each imaging time-point was
performed using an automated image processing pipeline [39].
All scans were first registered with 6 degrees of freedom (dof)
(to remove differences in position and orientation using a rigid-
body assumption) and 9 degrees of freedom (to optionally
remove global differences in scale using a growth model based
on uniform scaling) using a population based approach which
has proven robust in rodent imaging applications [40]. Then
each scan was non-rigidly registered to the WT mean at the
same time-point using a high-dimensional fluid registration
technique [41,42,43]. This technique models the coordinate
mapping between scans as the flow of a viscous fluid and can
successfully map large structural displacements as well as
smaller localized changes in shape. This technique has
previously been applied in other rodent models, e.g. structural
remodeling in stroke [39]. The fluid registration results in a
dense displacement field that maps each point in the original
scan to the corresponding point on the reference mean. From
this map, an estimate of apparent volume difference (the
Jacobian determinant) between the scan and the WT mean at
each voxel can be obtained. TBM analysis then applies voxel-
wise non-parametric t-tests to these volume difference
estimates to determine the location of statistically significant
differences in brain tissue volume of R6/1 compared with WT.
Significance levels are corrected for multiple comparisons
across voxels using the False Discovery Rate. The analysis
following 6 dof registration finds absolute volume differences
(i.e. the fluid registration includes differences in brain size and
the analysis finds absolute volume difference between
regions), whereas 9 dof registration finds volume differences
relative to whole brain volume, V (i.e. the fluid registration does
not include differences in global brain volume and the analysis
finds volume differences relative to whole brain volume).
Collectively, these analyses allow for the comparison of WT
versus R6/1 at each time point (three image sets in total, 9 and
17 weeks in vivo and 19 weeks ex vivo), as well as the age-
related change within each genotype (from 9 to 17 weeks of
age). A detailed methodological description of this approach
can be found in [39].
Histology
Upon completion of ex vivo imaging, brains were removed
from the skulls, rinsed in phosphate buffered saline (PBS) and
cryoprotected in 30% sucrose in PBS (+0.05% sodium azide)
until sectioning. Coronal sections were taken serially at 50 μm
thickness on a freezing microtome (HM430 Microm, Thermo
Scientific) and stored at -20°C in tissue cryoprotective solution
(+ 0.05% sodium azide) until staining. Histological processing
and data collection was performed identically to that described
previously in [19].
Immunohistochemistry.  Sections were washed in PBS
prior to incubation for 30 min in 3% H2O2 in PBS to quench
endogenous peroxidase activity. Non-specific binding was
blocked with a 1 h incubation in 10% normal serum with 0.3%
Triton X-100 in PBS. Sections were then incubated overnight at
4°C in primary antibodies against NeuN (1:500, Millipore,
Watford, UK) or S830 (1:2000), raised against exon 1 HTT with
53 glutamines [44], prior to incubation in appropriate
biotinylated secondary antibody (Vector, Peterborough, UK) for
2 h at RT, followed by 1 h incubation in an avidin-biotinylated-
peroxide complex (1:100, Vector, Northampton, UK). 3, 3'-
diaminobenzidine (Sigma-Aldrich, Poole, UK) was used as the
chromagen.
Cortical Thickness.  Assessment of regional cortical
atrophy was determined by thickness measurements of primary
motor cortex (M1) and primary sensory cortex (S1) on NeuN-
stained sections. In each region, 10 vertical lines were drawn
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covering all layers from the most dorsal horn of the corpus
callosum to the pial surface. The mean length taken was for 3
consecutive sections caudally from when the corpus callosum
bridges across the two hemispheres (approximately Bregma
+1.10 mm).
Stereology of NeuN-stained sections.  Unbiased
stereological estimates of volume and neuronal number were
obtained using StereoInvestigator software (Microbrightfield,
Willston, VT). All stereological measurements were performed
with the observer being blinded to the experimental grouping.
The Cavalieri method was used to obtain unbiased estimates
of striatal and M1 cortical reference volumes [45]. ROIs were
defined by x1.6 magnification lens through reference to
neuroanatomical landmarks. For both the striatum and M1
cortex, equally spaced sections (50 μm thickness each,
typically 4-6 sections with a 450 μm gap) were analyzed (see
Figure S1 for boundaries drawn on histological sections).
As defined by Sadikot and Sasseville [46], for striatal
measurements, sections were sampled anteriorly from the first
appearance of the genu of the corpus callosum (Bregma = +1.1
mm) to the first evidence of a hippocampal formation
posteriorly (Bregma = -0.94 mm). The dorsal and lateral
boundaries consisted of the corpus callosum with the medial
boundary being the lateral ventricles/external capsule. For
sections rostral to where the dorsal 3rd ventricle has joined the
lateral ventricles, ventral boundaries become lateral ventricles/
globus pallidus. The striatal volume was sampled on 4-5
sections for both WT and R6/1.
M1 cortex was measured anteriorly from +1.1mm Bregma to
posteriorly -0.94 mm Bregma, from layers II to VI, as defined in
the stereotaxic atlas [47]. The absence of cortical layer IV
(indicative of the S1 cortex) defined the lateral boundaries of
M1, whereas medial boundaries consisted of the most dorsal
part of the corpus callosum. M1 was sampled on 4-5 sections
for both WT and R6/1.
To obtain unbiased estimates of neuronal numbers, the
optical fractionator was employed as a stereological probe
(coefficient of error <0.1). Section thickness and neuronal
counts were performed under oil immersion with the x100
objective (Zeiss) with a numerical aperture of 1.4. A sampling
grid was applied appropriate to the structure measured (cortex
= 200 μm x 200 μm, striatum = 400 μm x 400 μm) with a
counting frame of 65 μm x 35 μm with a mean thickness of 18
μm. Guard zones of 0.5 μm were applied at the top and the
bottom of each frame with a mean dissector height of 17 μm.
Quantitative analysis of S830.  Evaluation of mHTT
immunoreactivity in different brain regions was performed using
an intensity-based measurement of S830 staining. Non-
overlapping images (using fixed exposure and light intensities
at x40) were obtained from 3 consecutive sections expressing
the striatum or hippocampus, and 6 sections for the cortex. In
total, 30 striatal (10 per section), 60 cortical (10 per section)
and 36 hippocampal subregion (12 per section) images were
taken. All images were captured in RGB using a live video
camera (JVC, 3CCD, KY-F55B), mounted onto a Zeiss
Axioplan microscope.
Staining intensity was quantified using threshold-based
analysis software (Image Pro Plus, Media Cybernetics, IL,
USA) assessing optical density of the immunoreactive product.
Threshold levels were chosen based on the minimum level of
transmitted light needed to detect the immunoreactive product
on a scale of 0 (100% transmitted light) and 255 (0%
transmitted light) for each pixel. Two levels were taken to
measure dense, nuclear mHTT inclusions (90), and total
aggregated mHTT staining (nuclear and extra-nuclear, 130);
mean percentage immunoreactivity area per field of view (FOV)
was recorded.
Statistical analyses
Data was graphed using Prism Ver.5.0b (GraphPad
Software, California, USA). Statistical analyses were calculated
using SPSS Statistics Ver.20 (IBM, Portsmouth, UK). All data
were screened for statistical outliers using Grubbs’ Test
(GraphPad Software, California, USA). Grubbs’ test calculates
a z ratio for each value within a given dataset (determined
through subtracting each value from the group mean, and
dividing it by the standard deviation). If the z ratio for any given
value is greater than those proposed by Grubbs for that
population size, it is considered an outlier. If this was the case,
the value was excluded from analysis. Due to either animal
loss (total of 2 cases, female R6/1 only), or occasional missing
data samples and removal of statistical outliers (total absent
data samples for male WT = 15, male R6/1 = 8, female WT = 8,
female R6/1 = 20), the number of animals varied for each test
at different time points. A table summarizing the number of
subjects included for each measure and the reason for
exclusion can be found in Table S1.
The acquired datasets can be separated into those that were
collected longitudinally, those acquired at a single time point,
correlational analyses, as well as Tensor Based Morphometry
statistics.
Longitudinal datasets.  These datasets refer to tests where
data was collected at more than one time point and include:
body weight assessment, body temperature assessment,
locomotor activity, grip strength measurements, behaviors in a
swimming T-maze and measurements of volumetry and T2
relaxivity through MRI. It was not possible to compute a
repeated measures ANOVA due to missing values at different
measurement times. To probe the influence and interaction of
genotype and gender across time, a three-way ANOVA was
applied (Genotype, Gender and Age, as between-subject
factors). To determine whether mice exhibit cued fear
conditioning extinction (i.e. a form of re-learning that the
conditioned stimulus is no longer aversive with repeated
exposure), a repeated measures ANOVA was used (repeated
Tone (conditioned stimulus) exposure as within-subject factor,
Genotype and Gender as between-subject factors). Post-hoc
tests with a Bonferroni Correction for multiple comparisons
were applied where appropriate. All main effects from ANOVAs
can be found in Table S2.
Datasets taken at a single time-point.  These data refer to
tests that were only conducted once during the study and
include: rotarod, odor discrimination, social interaction, fear
conditioning, and histological measures taken through
stereology. To probe the influence of genotype and gender on
these measures, a two-way ANOVA was applied (Genotype
Characterization of R6/1 Mouse Model of HD
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e84726
and Gender as between-subject factors). Post-hoc tests with a
Bonferroni Correction for multiple comparisons were applied
where appropriate. All main effects from ANOVAs can be found
in Table S2.
For the histological quantification of mHTT, there was an
absence of immunoreactivity in the WT mice. This marker,
within this group, was therefore not included in the analysis. To
compare levels of mHTT across various brain regions, and
probe the influence of gender on this measure a two-way
ANOVA was applied (Region and Gender as between-subject
factors). A post-hoc test was conducted for multiple
comparisons, with a Bonferroni Correction, comparing male
and female R6/1 mice at each brain region.
Correlative analyses.  The Pearson Correlation Coefficient
was used for all correlative analyses. To account for multiple
correlations of the same data, the significance level was
corrected using a Bonferroni Correction by dividing the
standard p value (0.05) by the number of comparisons made,
resulting in an appropriately adjusted p value for each dataset.
Tensor Based Morphometry Statstics.  As described in
[39], a non-parametric two-tailed t-statistic, assuming unequal
variance between groups, is computed at each voxel
(approximately 42,000) in the brain; permutation-testing is used
to assess significance. The effective number of permutations at
each voxel is increased by pooling null-distribution statistics
from other voxels to allow for accurate multiple comparisons
correction using the False Discovery Rate [48]. The minimum
number of required permutations is approximately (number-of-
voxels / FDR-significance-level) = 42,000 / 0.05 = 840,000.
Results
Physiological measures
Abnormal weight gain is a common feature of mouse models
of HD. Both male (Figure 1B) and female (Figure 1C) R6/1
mice had lower body weights at later ages compared to WTs
[F(Genotype X Age)4,195 =6.173, p<0.001]. Although there was
no interaction between gender and genotype [F(Genotype X
Gender)1,195=0.845, ns] weight loss reached statistical
significance for male mice at 19 weeks only (p=0.025, multiple
comparison with Bonferroni Correction). Overall, differences in
body temperature were detectable between WT and R6/1 mice
(data not shown; [F(Genotype)1,157=5.768, p=0.018]), but there
was no interaction with gender [F(Genotype X
Gender)1,157=0.18, ns] or age [F(Genotype X Age)3,157=0.293,
ns]. Moreover, upon post-hoc testing, when corrected for
multiple comparisons, there were no genotype-dependent
differences detected at any given time point.
R6/1 exhibit age-related motor and cognitive deficits
The presence of motor abnormalities is an important feature
of HD mouse models, here we tested WT and R6/1 mice at
three tasks designed to probe motor ability: rotarod, locomotor
activity and grip strength.
Motor-related-tasks.  Rotarod was tested at 11 weeks of
age only. There was an overall difference between the two
genotypes [F(Genotype)1,39=20.794, p<0.001], but no
interaction with gender [F(Genotype X Gender)1,39 =3.918, ns].
Despite having a lower performance compared to WTs at this
task, male R6/1s did not reach statistical significance (Figure
2A), whereas, female R6/1s were significantly impaired versus
WTs (p<0.001, Figure 2B).
Exploratory activity in the open field was assessed during the
dark cycle, at both 10 and 19 weeks of age. Overall, WT and
R6/1 mice behaved differently during this task
[F(Genotype)1,76=7.296, p=0.009], but there was no interaction
with either gender [F(Genotype X Gender)1,76=2.115, ns] or age
[F(Genotype X Age)1,76=0.443, ns]. After correcting for multiple
comparisons, exploratory activity exhibited by either male
(Figure 2C) or female (Figure 2D) R6/1 mice was not different
to WT controls at either age studied.
Grip strength capacity (forelimbs; simultaneous fore- and
hind limbs) was assessed at both 10 and 19 weeks of age.
Forelimb grip strength capacity of R6/1 mice changed over time
[F(Genotype X Age)1,77=6.712, p=0.012], but this was not
influenced by gender [F(Genotype X Gender)1,77=0.1, ns].
Maximum tension exhibited by both male (Figure 2E) and
female R6/1s (Figure 2F) dropped with age, with only males
being statistically different at 19 weeks (p=0.015). The grip
strength of the fore- and hind limbs, when taken together,
followed a similar pattern to that of the forelimbs only, as there
was an age-related change in performance between WTs and
R6/1s [F(Genotype X Age)1,77=13.107, p=0.001], and, again,
gender did not exert a significant influence [F(Genotype X
Gender)1,77=1.033, ns]. Maximum tension of the fore and hind
limbs of the R6/1s dropped to below that of WTs at 19 weeks of
age for both males (p=0.003, Figure 2G) and females
(p=0.016, Figure 2H).
Non-motor-related tasks.  Clinical signs of HD are not
restricted to motor abnormalities and these features should
also be recapitulated in mouse models for greater face validity.
To probe such non-motor behaviors, mice were exposed to
learning and memory paradigms (swimming T-maze and fear
conditioning), as well as measures of olfactory function (odor
discrimination) and recognition of social novelty (social
interaction).
The swimming T-maze was used for the assessment of cued
learning and its subsequent reversal at both 6 and 15 weeks of
age. Overall, the ability to learn a visual cue signifying an
escape route (termed “cue learning”) was different between WT
and R6/1 mice [F(Genotype)1,77 =5.066, p=0.028]. Despite
there not being a significant interaction with either gender
[F(Genotype X Gender)1,77=0.185, ns] or age [F(Genotype X
Age)1,77=2.663, ns], male R6/1s were not significantly different
to WT controls at either age (Figure 3A), but female R6/1 mice
took longer to learn the rule compared to female WTs at 15
weeks only (p=0.01, Figure 3B). Reversing the previously
learned cue-based rule, termed “cue reversal”, is a more
cognitively demanding task and this was reflected by the
generally longer trials required to reach criterion (on average
46.01% longer compared to the more simple cue learning).
There was an age-related difference in cue reversal learning
between WT and R6/1 mice [F(Genotype X Age)1,75=19.17,
p<0.001]. Similar to the cue learning phase of this task, gender
did not influence behavior at cue reversal [F(Genotype X
Gender)1,75=0.348, ns]. Post-hoc analyses revealed that at 6
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Figure 2.  Performance at motor-related tasks.  Both male (A) and female (B) R6/1 mice exhibited lower latency to fall from an
accelerating rotarod at 11 weeks of age, reaching statistical significance in the females only. Conversely there was no difference in
locomotor activity in an open field between WT and R6/1 mice at either 10 or 19 weeks of age (C & D). Forelimb grip strength (E &
F) declined with age in R6/1 mice, as did both fore- and hind limb strength when taken together (G & H). Rotarod analyzed using
two-way ANOVA (Genotype X Gender); locomotor activity and grip strength analyzed using three-way ANOVA (Genotype X Gender
X Age). Rotarod: WT male n=11, R6/1 male n=9, WT female n=10, R6/1 female n=10; Locomotor activity: WT male n=11, R6/1
male n=9, WT female n=10, R6/1 female n=8-9; Grip strength: WT male n=11, R6/1 male n=9, WT female n=10, R6/1 female
n=8-10. All data presented as means ± SEM; *p<0.05, **p<0.01, ***p<0.001.
doi: 10.1371/journal.pone.0084726.g002
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weeks of age R6/1 mice had a similar learning capacity to
WTs, but by 15 weeks both male (p=0.018, Figure 3C) and
female R6/1s (p=0.006, Figure 3D) took longer to learn this rule
compared to WT controls.
Fear conditioning relies upon the formation of a conditioned
fear response to an auditory tone and salient context, and
provides a measure of memory retention and extinction.
Performance at this task was investigated at 12 weeks of age
in WTs and R6/1s. On the training day, immediately following
the conditioning foot-shock exposure, there was no difference
in immobility (fear expression) between the WT and R6/1 mice
(data not shown; [F(Genotype)1,35=0.193, ns]) and there was no
influence of gender [F(Genotype X Gender)1,35=0.436, ns],
indicating a similar response to the conditioning protocol, and,
hence, memory acquisition. On the second day, all animals
were subjected to repeated exposure of the conditioning tone
without foot-shock administration to probe memory
performance. Initially mice expressed a robust fear response,
and, with repeated exposure to the tone, mice exhibited less
immobility ([F(Tone)4,27=6.879, p=0.001]; Figure 3E&F),
indicative of cue extinction learning. There was no interaction
between Genotype and the response to the repeated Tone
[F(Genotype X Tone)1,27=1.116, ns] suggesting a similar pattern
of extinction learning between WTs and R6/1s. However,
overall, fear response across all these tones was significantly
lower in R6/1s compared to WTs [F(Genotype)1,30=6.824,
p=0.014], indicating some abnormality in R6/1 performance at
this task, but there was no influence of gender on this behavior
[F(Genotype X Gender)1,30=0.042, ns]. On the third day of the
task, contextual recall was tested over 5 min. Overall R6/1
mice expressed less fear response compared to WTs
([F(Genotype)1,34=6.006, p=0.02]; Figure 3G&H), but this was
not influenced by gender [F(Genotype X Gender)1,34=0.004, ns].
These results imply an impaired memory performance in the
R6/1 mice at 12 weeks, but the exact nature of the deficit
remains unclear.
Olfaction was tested in the mice at 10 weeks of age using
the odor discrimination task (Figure 3I). There was no
difference in WT and R6/1 at the performance of this task
[F(Genotype)1,35=0.349, ns] and no effect of gender
[F(Gender)1,35 =0.204, ns]. Following the odor discrimination
task, mice were tested at their social interaction and ability to
determine novelty at 10 weeks. On the first part of the task,
time spent investigating an unfamiliar mouse was similar
between WTs and R6/1s [F(Genotype)1,39=0.936, ns], which
would suggest unaffected social behaviors in the R6/1s. At the
second part of the task (Figure 3J), (exposure to the “familiar”
mouse from the first trial along with a “novel mouse”), there
was no difference in preference for novelty between WT and
R6/1 [F(Genotype)1,38=0.253, ns], and no influence of gender
[F(Gender)1,38=0.704, ns].
To determine interactions and associations of performance
at these behavioral tasks (both motor- and non-motor-related),
a correlative analysis was performed. These analyses were
separated by age tested; behaviors measured between 6-12
weeks (Table S3) and behaviors measured between 15-19
weeks (Table S4). There were no significant correlations
between the performance at the various behavioral tasks
recorded between 6 and 12 weeks of age. However, at 15 to
19 weeks, a higher grip strength in the forelimbs only was
associated with higher grip strength in both the fore- and hind
limbs for the males (r=0.79, p<0.005). A longer time to learn
the cue reversal task in the swimming T-maze was only
associated with lower fore- and hind limb grip strength in
females (r=-0.669, p<0.005). These effects were only evident,
however, when considering both WT and R6/1 mice together,
and, therefore likely reflect the concomitant development of
impairments in two measures in R6/1 mice; as performance in
two measures declines over time, a strong correlation is formed
(Figure 4A&B).
R6/1 exhibit progressive brain atrophy
Alongside the detailed analysis of behavioral dysfunction in
R6/1 mice, longitudinal in vivo MRI was conducted at 9 and 17
weeks of age to investigate changes in neuroanatomy (Figure
5A). The striatum, hippocampus, cortex, corpus callosum and
whole brains were manually delineated and regional volumetry
and T2 relaxivity were measured in the same ROIs.
Longitudinal MR volumetry provides a measure of volume
change in the R6/1 mouse brain (Figure 5B). The whole brain
volume of R6/1 mice was different to WTs over time
[F(Genotype X Age)1,78=7.501, p=0.008]. In fact, R6/1s were
already 94.5% that of the WTs at 9 weeks of age, reaching
statistical significance for both the males (p=0.023) and
females (p=0.044), although there was no overall interaction
between genotype and gender [F(Genotype X
Gender)1,78=0.138, ns]. This difference was amplified at 17
weeks to 89.79%. Overall striatal [F(Genotype)1,78=26.481,
p<0.001], cortical [F(Genotype)1,78=61.667, p<0.001] and
hippocampal volumes [F(Genotype)1,78=64.687, p<0.001] were
different between WT and R6/1 mice, but this was not
influenced by gender (striatum [F(Genotype X
Gender)1,78=0.464, ns]; cortex [F(Genotype X
Gender)1,78=0.033, ns]; hippocampus [F(Genotype X
Gender)1,78=0.056, ns]). There was a significant interaction
between genotype and age in the cortex [F(Genotype X
Age)1,78=5.224, p=0.025] and hippocampus [F(Genotype X
Age)1,78=11.447, p=0.001], but, interestingly, this interaction
was not evident for the striatum [F(Genotype X Age)1,78=3.019,
ns]. A Bonferroni-corrected multiple comparison analysis
revealed no differences in these regional volumes at 9 weeks
of age, but by 17 weeks of age all three regions were
significantly smaller in the R6/1s: the R6/1 striatum was
82.36% that of WT (males p=0.008, females p=0.004); the
R6/1 cortex was 84.91% that of WT (males p<0.001, females
p<0.001); the R6/1 hippocampus was 82.49% that of WT
(males p<0.001, females p<0.001). There was no detectable
difference in corpus callosum volume at either 9 or 17 weeks of
age. Whole brain volume was significantly correlated with
cortical (r=0.708, p<0.0011) and hippocampal (r=0.693,
p<0.0011) volumes in female R6/1s (Table S5), suggesting a
relationship between changes in whole brain and sub-regional
volumes.
As well as measures of brain volumes, T2 relaxivity
measures (reflective of tissue composition) were taken in the
striatum, cortex, hippocampus, corpus callosum and muscle
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Figure 3.  Performance at non-motor-related tasks.  Male R6/1 mice did not exhibit any impairment in cue learning in the
swimming T-maze (A), whereas female R6/1 mice were deficient at 15 weeks of age (B). Both male (C) and female (D) R6/1s
developed an age related deficit in cue reversal learning in a swimming T-maze. There was no obvious difference in cued extinction
behavior between WTs and R6/1s (E & F), or a difference in contextual recall (G & H). At the odor discrimination task (I) and novel
social interaction test (J) there was no difference between the four groups. Swimming T-maze analyzed using three-way ANOVA
(Age X Genotype X Gender); fear conditioning cue extinction analyzed using a repeated measures ANOVA (Genotype X Gender X
Tone); fear conditioning context recall, odor discrimination and novel social interaction analyzed using a two-way ANOVA (Genotype
X Gender). Swimming T-maze: WT male n=10-11, R6/1 male n=8-9, WT female n=10, R6/1 female n=9-10; Fear conditioning: WT
male n=11, R6/1 male n=9, WT female n=7-8, R6/1 female n=7-8; Odor discrimination: WT male n=11, R6/1 male n=8, WT female
n=9, R6/1 female n=8; Novel social interaction: WT male n=10, R6/1 male n=9, WT female n=10, R6/1 female n=10. All data
presented as means ± SEM; *p<0.05, **p<0.01.
doi: 10.1371/journal.pone.0084726.g003
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tissue. There were few differences in regional T2 values
between WT and R6/1 mice (data not shown). Overall, T2
relaxation times were different between WTs and R6/1s in the
striatum [F(Genotype)1,77=13.294, p=0.001] and corpus
callosum [F(Genotype)1,76=4.403, p=0.04] only, there were no
interactions between genotype with age or gender in any
region studied. A post-hoc analysis revealed only a shortening
of T2 values between male WT and R6/1 mice at 9 weeks in
the striatum (p=0.002), cortex (p=0.009) and hippocampus
(p=0.039). There were no significant effects in the corpus
callosum or muscle tissue.
Compared to the volumetric data, T2 values across the
various brain regions studied were highly correlated with each
other for both WTs and R6/1s, irrespective of gender (Table
S5). This, however, was not the case for the corpus callosum
or muscle tissue. These data indicate that changes in T2
values are highly consistent and ubiquitous across grey matter
irrespective of mouse genotype. There were no significant
correlations between measures of volumetry and T2 relaxivity
with the exception of a smaller whole brain volume being
associated with higher T2 relaxation times in the male R6/1s
only (r=-0.756, p<0.0011).
The neuroanatomical basis of behavioral impairments is
reflected in associations between these two outcome
measures, thus a correlative approach to probe associations
between brain abnormalities detected through MRI and age-
matched functional impairments in behavioral tasks was taken
between early (between 6 and12 weeks) and later measures
(15 and 19 weeks) (Table S6). Only two significant
associations were detected after corrections for multiple
comparisons, both in early measures of behavior and MRI (6 to
12 weeks). When considering both WTs and R6/1s together,
longer hippocampal T2 relaxation was associated with
hyperactivity in an open field (r=0.702, p<0.001), evident in the
males only. Moreover, longer hippocampal T2 was also
associated with a lower immobility (memory recall) in the cued
fear conditioning task (r=-0.761, p<0.001), but in the females
only.
TBM analysis revealed sub-region specific and gender-
dependant differences in the R6/1 brain atrophy
Although informative, manually segmented ROI analysis has
some limitations, such as a lack of sub-regional specificity and
the selective choice of regions to be studied. Tensor Based
Morphometry (TBM), an automated image analysis, allows for
the unbiased detection of changes in individual voxels across
the whole brain irrespective of their ROI assignment. TBM was
used to compare WT and R6/1 brains at three time points
scanned, 9 weeks and 17 weeks in vivo, and 19 weeks ex vivo
for males (Figure 6) and females (Figure 7). Although there
was evidence of global brain volume shrinkage (6 dof) in male
R6/1 mice at 9 weeks (Figure 6A), but not female (Figure 7A),
there was no specific regional differences when corrected for
whole brain volume change for either gender (9 dof). By 17
weeks there was a substantial shrinkage of both whole brain
volume (Figure 6B), as well as sub-regions when corrected for
global volume change in male mice only. Specifically, these
analyses revealed subtle expansion of posterior ventricular
spaces and, interestingly, in R6/1s, a spared hippocampal
volume. Similar to that detected through the manually
segmented analysis, the TBM analysis also indicates that the
male R6/1 cortex suffered atrophy, but this advanced technique
Figure 4.  Concomitant deficits in behavioral tasks result in a robust correlation of those two measures.  (A) At 18 weeks of
age R6/1 mice have both lower forelimb, and fore- and hind limb grip strength capacity to a similar degree, separating the data from
those of WT resulting in a significant, positive correlation (r=0.79, p<0.005). (B) Between 15-19 weeks of age R6/1 mice have lower
fore- and hind limb grip strength, as well as impaired cue reversal learning in a swimming T-maze to a similar degree, forming a
strong overall negative correlation (r=-0.669, p<0.005).
doi: 10.1371/journal.pone.0084726.g004
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allows for a more precise description of this change, as it is
apparent that TBM has revealed a global cortical atrophy, but
with a relative sparing of the cingulate cortex (at Bregma
~0.26-0.46 mm). These TBM analyses provide more precise
evidence of sub-regional changes that occur within large brain
regions, such as the cortex.
Female R6/1s had robust global volume differences (6 dof),
but no sub-regional changes (9 dof) were evident even at 17
Figure 5.  Longitudinal in vivo MRI.  (A) Summed T2-weighted structural group-images from WT and R6/1 mice at 9 and 17
weeks of age. (B) R6/1 mice progressive lost regional brain volumes compared to WT controls, with the exception of the corpus
callosum (C. Callosum). Analyzed using a three-way ANOVA (Genotype X Gender X Age). Striatum, cortex, hippocampus, corpus
callosum and whole brain: WT male n=11, R6/1 male n=9, WT female n=10, R6/1 female n=9-10. All data presented as means ±
SEM; *p<0.05, **p<0.01, ***p<0.001.
doi: 10.1371/journal.pone.0084726.g005
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weeks (Figure 7B). These effects are similar, but more robust
and better defined, on the analysis of the ex vivo images taken
at 19 weeks, where differences between male (Figure 6C) and
female mice (Figure 7C) were less evident. Interestingly, for
both genders, the greatest magnitude of shrinkage was evident
in the posterior striatum at Bregma ~ -1.22 mm, and substantial
cortical atrophy was evident, specifically in the retrosplenial
areas, visible at Bregma ~ -2.46 mm.
In order to determine specific age-related alterations within
each separate genotype, a longitudinal analysis was conducted
to compare these across time for both male (Figure 8) and
female (Figure 9) mice. Unexpectedly, male WT mice had no
global brain volume changes over time, but did show some
evidence of specific sub-regional brain changes, principally a
shrinkage of the anterior striatum and a ubiquitous cortical
atrophy, whist posterior ventricular spaces were enlarged,
(Figure 8A), whereas there were no age-related differences in
female WT mice (Figure 9A). Both male (Figure 8B) and female
(Figure 9B) R6/1 mice exhibited global brain volume change
and specific regional changes when corrected for whole
volume change. Indeed, both male and female R6/1 mice
exhibited a ubiquitous shrinkage of the striatum over time,
whereas, within the cortex, the somatosensory cortices were
dramatically atrophied at Bregma ~1.22 mm. Interestingly, for
both WT and R6/1 mice, the corpus callosum remained
relatively unchanged with age, consistent with manually
segmented ROIs.
In summary, both methods of measuring volume change
from MRI (i.e. manually segmented volumetry and automated
TBM) detected robust shrinkage of grey matter tissue, and a
relative sparing of white matter tissue, in R6/1 mice with age.
Nevertheless, TBM allowed for a more precise description of
the anatomical loci of these changes.
R6/1 mice express HD-like histopathological features,
including neuronal loss
In order to determine the molecular and neurological basis
for the behavioral dysfunction and brain atrophy observed
through MRI, a histopathological investigation was conducted.
The deposition of mHTT is a neuropathological hallmark of HD.
We used the S830 antibody to independently visualize nuclear
mHTT inclusions, as well as other forms of aggregated mHTT
in both the nucleus and neuropil (referred to here as total
aggregated mHTT) in the R6/1 mouse brain (Figure 10A). S830
reactivity was negligible in WT (percentage striatal FOV
immunoreactive was 0.16%), indicating that it reflects a
neuropathological marker in the R6/1 genotype. In R6/1s, the
levels of mHTT varied across brain regions for both nuclear
mHTT inclusions [F(Region)5,102 =17.808, p<0.001] and total
mHTT aggregates [F(Region)5,104=86.98, p<0.001]. However,
Figure 6.  Brain volume changes in male WT and R6/1 assessed through TBM.  Maps of local volumetric changes in male R6/1
mice compared to male WT 9 weeks in vivo (A), 17 weeks in vivo (B), and at 19 weeks ex vivo (C). Images presented as either both
global volume change (6 dof), or region-specific changes corrected for global change (9 dof). Color scales are for volume difference
(Volume diff., blue-to-yellow), and the raw t statistical value at each voxel (dark-to-light green). Only volume changes and effects-
sizes which survive multiple comparisons corrections across all voxels in the brain (False Discovery Rate with q<0.05) are shown.
doi: 10.1371/journal.pone.0084726.g006
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there was no influence of gender on either measure (nuclear
mHTT: [F(Gender X Region)5,102=0.675, ns]; total mHTT:
[F(Gender X Region)5,104=0.503, ns]). Indeed, a post-hoc
analysis revealed that there was no gender-dependent
difference between either the nuclear inclusions (Figure 10B)
or total aggregated mHTT (Figure 10C) levels in the striatum,
cortex or hippocampal subfields (dentate gyrus, CA1, CA2 or
CA3). Generally, mHTT levels were positively correlated across
all brain regions (Table S7). When considering male and
female R6/1s together, total levels of mHTT were highly
correlated across the CA1, CA2 and CA3 hippocampal
subfields (r>0.753, p<0.0008), indicating a more ubiquitous
detection in these areas. Interestingly, on TBM analysis of MRI,
the hippocampus exhibited little atrophy despite a heavy
molecular pathology.
A stereological analysis of sections, stained for the neuronal
marker NeuN (Figure 11A), revealed lower neuronal numbers
in R6/1 compared to WTs, evident in both the striatum
([F(Genotype)1,37=14.546, p=0.001]; Figure 11B) and M1 cortex
([F(Genotype)1,36=15.432, p<0.001]; Figure 11C). There was no
influence of gender on this drop in R6/1 neuronal number in
either region (striatum: [F(Genotype x Gender)1,37=0.535, ns];
M1 cortex: [F(Genotype X Gender)1,36=0.55, ns]). The
substantially smaller regional volumes in the R6/1s (striatum by
76.35% of WTs, M1 cortex by 81.35%) accompanied by this
drop in neuronal numbers (striatum by 80.49% of WTs, M1
cortex by 84.29%) resulted in an absence of change in
neuronal density in either region (Figure 11D&E; striatum:
[F(Genotype)1,37=1.205, ns]; M1 cortex: [F(Genotype)1,36=0.837,
ns]). Changes in neuronal number and volume were
accompanied by substantial cortical thinning (Figure 11F) in
both the M1 cortex [F(Genotype)1,35=92.105, p<0.001] and
primary somatosensory (S1) cortex [F(Genotype)1,35=68.558,
p<0.001], but gender had no influence on these measures (M1
cortex: [F(Genotype X Gender)1,35=0.55, ns]; S1 cortex
[F(Genotype X Gender)1,35=1.347, ns]).
Generally, there was a tendency towards strong positive
correlations between neuronal number and neuronal density in
the striatum of both WTs (males r=0.949, p<0.0033; females
r=0.876, p<0.0033) and R6/1s (males r=0.927; p<0.0033,
females r=0.825, ns), but not in the M1 cortex (Table S8).
Interestingly there was no significant correlation between
neuronal numbers in the striatum and M1 cortex for R6/1s
(males r=0.079, ns; females r=0.638, ns) indicating that
changes in neuronal number of R6/1 mice may not occur
ubiquitously across the brain.
Figure 7.  Brain volume changes in female WT and R6/1 assessed through TBM.  Maps of local volumetric changes in female
R6/1 mice compared to female WT 9 weeks in vivo (A), 17 weeks in vivo (B), and at 19 weeks ex vivo (C). Images presented as
either both global volume change (6 dof), or region-specific changes corrected for global change (9 dof). Color scales are for volume
difference (Volume diff., blue-to-yellow), and the raw t statistical value at each voxel (dark-to-light green). Only volume changes and
effects-sizes which survive multiple comparisons corrections across all voxels in the brain (False Discovery Rate with q<0.05) are
shown.
doi: 10.1371/journal.pone.0084726.g007
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The histopathological basis of brain abnormalities and
behavioral impairments
By 17 weeks of age, R6/1 mice exhibited substantial brain
atrophy visualized through MRI. By combining this imaging
along with measures of histopathology, it is possible to
investigate potential mechanisms behind this apparent brain
volume loss. Nevertheless, there were no detectable
associations between mHTT load and MRI-based regional
brain changes (Table S9). Similarly, when considering the
relationship between NeuN-based stereological data and MRI
measures of brain abnormalities (Table S10), there were no
correlations for R6/1 mice. Importantly, there was no
correlation between neuronal numbers in either the striatum or
M1 cortex with any MR measures of pathology, which may
suggest that other, non-neuronal histopathological changes in
the brain could have a greater or more direct influence on
atrophy. Nevertheless, when considering male WT and R6/1
mice together, striatal volume determined through stereology
strongly correlated with most MR-volumetry (striatum r=0.727,
p<0.0033; cortex r=0.752, p<0.0033; hippocampus r=0.794,
p<0.0033), indicating that indeed these two outcome measures
were probing the same anatomical changes.
Through combining assessments of behavioral performance
with histopathological abnormalities, potential neurobiological
Figure 8.  Age-related evolution of brain atrophy in male mice measured through TBM.  Maps of local volumetric change in
both male WT (A) and male R6/1 mice (B) between the two time points (9 and 17 weeks of age). Images presented as either global
volume change (6 dof) or regional-specific changes corrected for global change (9 dof). Color scales are for volume difference
(Volume diff., blue-to-yellow) and the raw t statistical value at each voxel (dark-to-light green). Only volume changes and effects-
sizes which survive multiple comparisons corrections across all voxels in the brain (False Discovery Rate with q<0.05) are shown.
doi: 10.1371/journal.pone.0084726.g008
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mechanisms underlying functional deficits in R6/1 mice can be
examined. Levels of mHTT in the brain, however, did not
correlate with age-matched behavioral performance (Table
S11), with the exception of a higher mHTT inclusion level in the
hippocampal CA2 being associated with greater impairments in
the swimming T-maze “cue-reversal” learning (r=0.925,
p<0.0017). Similarly, behavioral performance did not show any
association with stereological measures of pathology in the
R6/1s (Table S12), with the exception of a smaller striatum
being associated with an impaired learning at the cue learning
phase of the swimming T-maze (r=-0.652, p<0.0033). Taken
together, despite a few correlations of histological measures
with single behavioral findings, there was an absence of direct
correlative associations between these two outcome measures.
It is therefore possible that a more complex relationship exists
between the HD-like neuropathology and subsequent
behavioral impairments in these mice.
Figure 9.  Age-related evolution of brain atrophy in female mice measured through TBM.  Maps of local volumetric change in
both female WT (A) and female R6/1 mice (B) between the two time points (9 and 17 weeks of age). Images presented as either
global volume change (6 dof) or regional-specific changes corrected for global change (9 dof). Color scales are for volume
difference (Volume diff., blue-to-yellow) and the raw t statistical value at each voxel (dark-to-light green). Only volume changes and
effects-sizes which survive multiple comparisons corrections across all voxels in the brain (False Discovery Rate with q<0.05) are
shown.
doi: 10.1371/journal.pone.0084726.g009
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Figure 10.  mHTT accumulation in R6/1 mice.  (A) Representative coronal sections from 19 weeks’ old WT and R6/1 mouse
brains stained with the S830 antibody for the detection of mHTT. Levels were quantified within seven brain regions using an
intensity threshold-based image analysis tool optimized for the detection of nuclear inclusions, or total levels of aggregated mHTT
(neuropil aggregates and diffuse nuclear accumulation, highlighted in blue); scale bar 50μm. Field of views (FOVs) were sampled in
the cortex, striatum and hippocampal subfields. Percentage of FOVs positive for S830 stain of nuclear inclusions (B), and
percentage of FOV positive for total aggregated mHTT (C), there were no significant differences between male and female R6/2 for
either assessments. Regional differences in mHTT reflect cellular density. STR = striatum, CTX = cortex, DG = dentate gyrus, CA1
= hippocampal CA1 subfield, CA2 = hippocampal CA2 subfield, CA3 = hippocampal CA3 subfield. Analyzed using a two-way
ANOVA (Gender X Region). All brain regions investigated: R6/1 male n=8-9, R6/1 female n=7-9. Data presented as means ± SEM.
doi: 10.1371/journal.pone.0084726.g010
Characterization of R6/1 Mouse Model of HD
PLOS ONE | www.plosone.org 17 December 2013 | Volume 8 | Issue 12 | e84726
Figure 11.  Histological analyses of NeuN-stained sections.  (A) Sample images of 19 week old WT and R6/1 coronal sections
stained for NeuN; scale bar 50 μm. There was a lower number of neurons in the striatum (B) and M1 cortex (C) in R6/1 mice, but no
difference in neuronal density in these two regions (D & E). There was substantial cortical thinning (F) in both the M1 and S1 cortical
subfields in R6/1 mice. All data analyzed using a two-way ANOVA (Genotype X Gender). Striatal measures of stereology: WT male
n=10, R6/1 male n=9, WT female n=10, R6/1 female n=9; M1 cortical measures of stereology: WT male n=10, R6/1 male n=8, WT
female n=10, R6/1 female n=9; cortical thickness in M1: WT male n=9, R6/1 male n=8, WT female n=10, R6/1 female n=9, and S1:
WT male n=9, R6/1 male n=9, WT female n=9, R6/1 female n=9. All data presented as means ± SEM; *p<0.05, ***p<0.001.
doi: 10.1371/journal.pone.0084726.g011
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Discussion
Establishing how molecular pathology in Huntington’s
disease (HD) leads to structural brain changes and the
emergence of functional abnormalities remains a major
challenge, both clinically in HD sufferers, and preclinically in
mouse models of the disease. Moreover, for HD animals to be
effective models in discovering novel therapeutic strategies, we
need an understanding of how the disease-like phenotypes
develop and relate to one another.
Using an interdisciplinary approach, we have provided a
detailed description of the progressive behavioral phenotype,
brain atrophy and neuropathological abnormalities, akin to
those observed in HD, in the transgenic R6/1 mouse model.
The key findings were 1) R6/1 mice exhibited age-related
deficits in both motor and cognitive behaviors detectable by 11
weeks of age; 2) MRI revealed the first changes in the R6/1
brain preceding behavioral dysfunction, as there was a smaller
whole brain volume already at 9 weeks of age, although
atrophy in various brain regions was only apparent later at 15
weeks; 3) accompanying these behavioral and brain
abnormalities were typical HD histopathological features,
including mHTT accumulation and neuronal loss; 4) there was,
however, little evidence that there is a strong association
between these typical histopathological markers of HD and
behavioral deficits suggesting that other neurobiological
changes might play an important role in the development of the
impairments observed in HD.
R6/1 mice mimic key clinical HD signs
Given the multi-faceted nature of clinical HD phenotypes, it is
essential to thoroughly characterize the different animal models
aiming to replicate the progressive pathology, as well as the
behavioral phenotype of HD. To characterize behavioral
changes in the R6/1 mouse model of HD, a battery of tests
aimed at probing motor and cognitive capabilities was applied
to investigate the emergence of deficits across different
functions.
The earliest detectable abnormality was a motor coordination
impairment on the rotarod at 11 weeks of age, although it is
important to note that this was the earliest age tested and it is
therefore possible that this deficit even precedes this age. This
early impairment is consistent with a deficit detected in a
previous study even earlier, at 2 months of age [20]. This motor
coordination task is therefore a useful marker for early HD-like
phenotype detection, detectable even before overt body weight
loss. Interestingly, this task was found to be impaired in the
R6/2 at a similar age, developing around 9 and 13 weeks [19].
We also noted robust decreases in grip strength, which
developed between 10 and 19 weeks of age. To our
knowledge, this is the first description of the progressive
development of grip strength deficits in this mouse line,
although it has been well described in R6/2 mice [49,50,51].
These impairments reflect the decline of neuromuscular
function and muscle strength, common features of HD. General
activity in an open-field, however, was unaltered in R6/1 mice.
These data are consistent with those showing an absence of
altered R6/1 activity measures over 30 min up to 14 week of
age [52]. Yet, others reported diminished exploratory activity as
a late (23 weeks, [53]), as well as an early phenomenon (6
weeks, [54]) in R6/1 mice. Longer (24h) assessments of
locomotor activity revealed also evidence of hypoactivity from
18 weeks of age [55]. Comparing activity assessments in R6/1s
from various literatures is nevertheless difficult given the gross
inconsistencies of testing conditions.
In addition to motor impairments, R6/1 mice developed
deficits in visuo-spatial cue-based learning, and its subsequent
reversal, at 15 weeks of age. The neuroanatomical
mechanisms underlying these two distinct forms of learning are
complex, but the reversal of cued learning requires a higher
degree of cognitive flexibility. Consequently, this is more
cognitively demanding, as reflected by the length of time taken
to acquire the new rule. Orbital and prefrontal cortex [56], as
well as frontostriatal brain regions [57] have been implicated in
variants of reversal learning in mice. Abnormalities in the
neuronal functioning within these regions have been stipulated
to be involved in reversal learning deficits in several HD mouse
models, including the R6/2 line [58,59,60]. Consistent with
these observations, we found that smaller striatal volumes
were associated with cue-reversal learning deficits in female
R6/1s.
Neuropathological correlates of behavior
As expected, we detected the extensive accumulation of
mHTT in the R6/1 mouse brain. As in the R6/2 mouse line [19],
there were no differences in protein abundance between male
and female R6/1 mice. It is worthy of note that the relative
amount of mHTT in the R6/1 brain regions investigated is
comparable to those in the R6/2. In the current study, we
quantified mHTT levels at 19 weeks of age only, however, a
previous characterization has demonstrated mHTT presence in
the R6/1 brain from as early as 2 months, which greatly
increased by 4 months [21].
The R6/1 and R6/2 lines had other similarities in brain
pathology expression, as both models exhibited a reduction in
brain volumes over time, detected here using longitudinal in
vivo MRI. As with the R6/2 mice [19], the R6/1 striatum
appears not to shrink over time, but rather does not grow at the
same rate as WTs. A similar effect of this absence of normal
striatal growth in the R6/1, rather than regional shrinkage, has
been detected previously through histological methods [21].
Interestingly, unlike the striatal volume that remains relatively
stable from 9 to 17 weeks (only a 4.19 % drop), the cortical
volumes appear to shrink more significantly over time (13.24%
drop). Again, these patterns of regional brain volume change
are consistent with those described in the R6/2 mice previously
[19]. These regional patterns of brain changes are distinct from
those generally observed in clinical investigations of
longitudinal brain atrophy in HD. MRI has detected progressive
atrophy of both the basal ganglia and neocortex [61], but others
have shown progressive atrophy of the striatum in patients with
>10 years of HD onset, and this progresses with disease
[62,63], although general grey-matter changes could not be
detected as early [62]. Indeed, striatal volume loss was a good
predictor of disease diagnosis in a separate study [64].
Therefore, unlike our recent data from mouse models, the
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evidence from clinical studies of HD indicate a robust, early
change in striatal volume in HD sufferers which continues to
develop as the disease progresses.
Alongside manually segmented ROI volumetry studies, TBM
allowed an unbiased, sensitive, assessment of volume change
across the whole brain, including sub-regional changes [65,66].
Interestingly, TBM revealed a more substantial pathology in the
male R6/1 mice compared to females, a phenomenon that was
less easy to resolve through manual segmentation.
Collectively, both manually defined MR volumetry and TBM
demonstrated age-related loss of grey matter, whilst sparing
white matter in the R6/1 mice. However, TBM allowed for more
precise detection of shrinkage of anatomical loci within larger
brain regions, such as retrosplenial areas alongside a relatively
spared anterior cingulate within the cortex. Interestingly,
although there was a general widespread atrophy occurring
across the whole brain in R6/1, the hippocampus was generally
spared, despite this region being heavily impacted by mHTT.
Despite various similarities with R6/2 mice, there were also
several key differences in the pathological progression of R6/1
mice. One major difference between the brain pathology of the
R6/1 and R6/2 mice is the presence of neuronal loss in R6/1s.
Previously, we have detected no difference in neuronal number
in R6/2 mice at 14 weeks of age [19], however, we detected
neuronal loss in the brain of R6/1 mice at 19 weeks of age,
consistent with a previous study which also described neuronal
loss in R6/1 [21]. There were no correlations between neuronal
loss and brain region volume change in the R6/1 mice, which
may indicate that non-neuronal changes are responsible for the
gross brain volume change in the R6/1. Such changes may
include loss of microglia and extracellular matrix molecule, both
being features of R6/2 mice [67,68]. Neuronal density was
highly elevated in R6/2 mice [19], which was likely a result of a
lack of neuronal loss coupled with restricted striatal growth.
Conversely, in the current study R6/1 mice exhibit both
neuronal loss and volume differences compared to WT mice,
thus resulting in a normal cellular density. Heightened cellular
density in the R6/2 mice may have resulted in lowered tissue
water content, which would, as a result, shorten T2 relaxation
values. It is therefore conceivable that the absence of cellular
density change in the R6/1s, results in normal tissue water
content levels and hence, the generally unaffected tissue T2
relaxation values described here.
To determine whether there were clear neuropathological
substrates responsible for the robust behavioral dysfunction, a
correlative analysis was performed between these two
outcome measures. There were few associations between
brain abnormalities determined through MRI and age-matched
behavioral performance, although both progressively worsened
with age in the R6/1. Studies have revealed that abnormal
neuronal functioning underlies behavioral dysfunction in the
R6/2 mouse line [69,70], and a disrupted neuronal activity has
also been reported as in R6/1 mice [71]. It is therefore possible
that abnormalities in neuronal activity, rather than brain tissue
loss, underlie the functional phenotypes in R6 mice.
Intensive behavioral testing may be detrimental to
longitudinal studies
R6/1 mice typically survive until around 40 weeks of age [5],
and can be behaviorally characterized up to 7 months of age
[20]. The current investigation took the R6/1 mice to 18 weeks
of age, whereby they reached a predetermined humane
endpoint approximately 12 weeks earlier than anticipated. The
experiment was consequently stopped. Given the nature of the
intense behavioral characterization undergone here, as well as
the repeated anesthesia for MRI, this may be in part
responsible for an anticipation of the humane endpoint. It is
hence important to consider the here presented results in this
context.
As detailed in the experimental design, mice were subjected
first to repeated swimming exposure followed by an intense
four weeks of behavioral testing. Alongside our test animals, a
separate cohort of WT and R6/1 mice were aged for tissue
collection. Body weight, a common, albeit superficial measure
of animal welfare, was lower in the animals exposed to the
intense behavioral exposure for both WTs (10.85% lower) and
R6/1s (13.58% lower). The increase in general activity and
exercise during behavioral testing is likely to reduce body
weight at the same caloric intake.
Unexpected and uncontrollable stressors have historically
been used to model many functional deficits associated with
depression in laboratory animals [72] and standard paradigms
aimed at probing behavior in animals can themselves induce
states of anxiety and emotional stress [73]. Indeed, elevated
levels of the stress-response hormone, corticosterone,
interferes with normal cognitive functioning [74]. This is of
particular concern when studying animal models of brain
disorders given the well described interactions between
emotional stressors and neurodegenerative disease [75]. In
fact, it is possible that transgenic models of HD are more
susceptible to stress-related insults given a hyperactivity of the
stress-response pathway, the hypothalamic-pituitary-adrenal
(HPA) axis, as has been reported in both R6/2 [76] and R6/1
[77] mice. The extent, intensity and duration of behavioral
characterization of R6 mice (regardless of any possible
heightened susceptibility to stress-related insults) should
therefore be carefully considered, as there is a risk of modifying
disease progression.
Conclusions
This study demonstrated both motor and cognitive deficits in
the R6/1 mouse line with concomitant brain atrophy as
determined through MRI. Accumulation of mHTT and a loss of
neurons in key brain structures was also evident post-mortem,
indicating that neurobiological changes underlie changes in
brain structure and behavior. However, there was little
evidence of a direct link between brain pathology and
behavioral deficits. The R6/1 mouse line therefore replicates
several key behavioral and neuropathological features of HD,
but presently no mechanistic link between these could be
established. Investigation of the early stages of behavioral
impairments in this model combined with a more extensive
histopathological and molecular analysis might be required to
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establish specific associations that link molecular pathology to
a specific behavioral deficit.
Supporting Information
Figure S1.  Striatal and M1 cortical inclusion criteria for
stereology. Sample coronal brain sections stained with NeuN
with guides of neuroanatomical boundaries for inclusion of the
striatum and M1 cortex for stereological analysis.
(TIF)
Table S1.  Number of animals used. All tests were conducted
on the same cohort of animals. However, there was a variable
subject number for each test due to either death during the
study, to the occasional missing data sample or to the
exclusion of statistical outliers. RR = rotarod, LMA = locomotor
activity in an open field, GS FL = grip strength of the fore-limbs,
GS 4L = grip strength of the fore- and hind limbs, TM CL =
swimming T-maze cue learning, TM CR = swimming T-maze
cue reversal, FC CS = fear conditioning cue recall (total
immobility over 25 cue exposures), FC CT = fear conditioning
contextual recall, OD = odor discrimination, SI = social
interaction, STR = striatum, CTX = cortex, HIPP =
hippocampus, CC = corpus callosum, WB = whole brain,
MUSC = muscle tissue, DG = dentate gyrus, CA1 =
hippocampal CA1 subfield, CA2 = hippocampal CA2 subfield,
CA3 = hippocampal CA3 subfield, M1 CTX = M1 cortex, S1
CTX = S1 cortex.
(PDF)
Table S2.  Main effects derived from statistical analyses.
Main effects derived from two-way and three-way ANOVAs.
LMA = locomotor activity in an open field, GS FL = grip
strength of the forelimbs, GS 4L = grip strength of the fore- and
hind limbs, TM CL = swimming T-maze cue learning, TM CR =
swimming T-maze cue reversal, RR = rotarod, OD = odor
discrimination, SI = social interaction, FC CS = fear
conditioning cue recall (total immobility over 25 cue
exposures), FC CT = fear conditioning contextual recall, STR =
striatum, CTX = cortex, HIPP = hippocampus, CC = corpus
callosum, WB = whole brain, MUSC = muscle tissue, DG =
dentate gyrus, CA1 = hippocampal CA1 subfield, CA2 =
hippocampal CA2 subfield, CA3 = hippocampal CA3 subfield,
M1 CTX = M1 cortex, S1 CTX = S1 cortex.
(PDF)
Table S3.  Correlations of behavioral measures taken
between 6 and 12 weeks. Correlations of performance at
behavioral tasks tested between 6 and 12 weeks, presented as
Pearson r values. RR = rotarod, LMA = locomotor activity in an
open field, GS FL = grip strength of the forelimbs, GS 4L = grip
strength of the fore- and hind limbs, TM CL = swimming T-
maze cue learning, TM CR = swimming T-maze cue reversal,
FC CS = fear conditioning cue recall (total immobility over 25
cue exposures), FC CT = fear conditioning contextual recall,
OD = odor discrimination, SI = social interaction.
(PDF)
Table S4.  Correlations of behavioral measures taken
between 15 and 19 weeks. Correlations of performance at
behavioral tasks tested between 15 and 19 weeks, presented
as Pearson r values. LMA = locomotor activity in an open field,
GS FL = grip strength of the forelimbs, GS 4L = grip strength of
the fore- and hind limbs, TM CL = swimming T-maze cue
learning, TM CR = swimming T-maze cue reversal.
*Statistically significant after Bonferroni Correction (adjusted p
value 0.005).
(PDF)
Table S5.  Correlations of MRI measures. Correlations of
measures of pathological burden assessed through MRI across
time, presented as Pearson r values. STR = striatum, CTX =
cortex, HIPP = hippocampus, CC = corpus callosum, WB =
whole brain, MUSC = muscle tissue. *Statistically significant
after Bonferroni Correction (adjusted p value 0.0011).
(PDF)
Table S6.  Correlations of behavioral abnormalities against
brain abnormalities determined through MRI. Correlations
of behavioral data against age-matched MRI measures taken
between either 6 and 12 weeks (matched to 9 week MRI data)
and 15 and 19 weeks (matched to 17 week MRI data),
presented as Pearson r values. RR = rotarod, LMA = locomotor
activity in an open field, GS FL = grip strength of the forelimbs,
GS 4L = grip strength of the fore- and hind limbs, TM CL =
swimming T-maze cue learning, TM CR = swimming T-maze
cue reversal, FC CS = fear conditioning cue recall (total
immobility over 25 cue exposures), FC CT = fear conditioning
contextual recall, OD = odor discrimination, SI = social
interaction, STR = striatum, CTX = cortex, HIPP =
hippocampus, CC = corpus callosum, WB = whole brain,
MUSC = muscle tissue. *Statistically significant after Bonferroni
Correction (adjusted p value 0.001).
(PDF)
Table S7.  Correlations of mHTT abundance across
different brain regions. Correlations of total detectable mHTT
(Total aggregated mHTT) and nuclear inclusions (Nuc mHTT)
across the six brain regions investigated in 19 week old R6/1
mice only, presented as Pearson r values. STR = striatum,
CTX = cortex, DG = dentate gyrus, CA1 = hippocampal CA1
subfield, CA2 = hippocampal CA2 subfield, CA3 = hippocampal
CA3 subfield. *Statistically significant after Bonferroni
Correction (adjusted p value 0.0008).
(PDF)
Table S8.  Correlations of neuronal characteristics.
Correlations of neuronal number (Neur no.), density (Neur
dens.) and regional volume determined through stereological
analyses of NeuN-strained brain sections in 19 week old mice,
presented as Pearson r values. STR = striatum, M1 CTX = M1
cortex. *Statistically significant after Bonferroni Correction
(adjusted p value 0.0033).
(PDF)
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Table S9.  Correlations of mHTT levels versus MRI
measures of brain abnormalities. Correlations of both post-
mortem (at 19 weeks) total aggregated mHTT levels and
nuclear inclusions (Nuc mHTT) against measures of brain
pathology through MRI at 17 weeks, presented as Pearson r
values. STR = striatum, CTX = cortex, DG = dentate gyrus,
CA1 = hippocampal CA1 subfield, CA2 = hippocampal CA2
subfield, CA3 = hippocampal CA3 subfield, HIPP =
hippocampus, CC = corpus callosum, WB = whole brain,
MUSC = muscle tissue.
(PDF)
Table S10.  Correlations of neuronal characteristics versus
MRI measures of brain abnormalities. Correlations of post-
mortem neuronal number (Neur no.), density (Neur dens.) and
regional volume determined through stereology on NeuN-
stained brain sections against measures of brain pathology
through MRI at 17 weeks of age, presented as Pearson r
values. STR = striatum, M1 CTX = primary motor cortex, CTX =
cortex, HIPP = hippocampus, CC = corpus callosum, WB =
whole brain, MUSC = muscle tissue. *Statistically significant
after Bonferroni Correction (adjusted p value 0.0033).
(PDF)
Table S11.  Correlations of mHTT levels versus behavioral
performance. Correlations of post-mortem (19 weeks) total
mHTT and nuclear inclusions (Nuc mHTT) against behavioral
phenotypes exhibited by R6/1 mice between 15 and 19 weeks
of age, presented as Pearson r values. LMA = locomotor
activity in an open field, GS FL = grip strength of the forelimbs,
GS 4L = grip strength of the fore- and hind limbs, TM CL =
swimming T-maze cue learning, TM CR = swimming T-maze
cue reversal, STR = striatum, CTX = cortex, DG = dentate
gyrus, CA1 = hippocampal CA1 subfield, CA2 = hippocampal
CA2 subfield, CA3 = hippocampal CA3 subfield. *Statistically
significant after Bonferroni Correction (adjusted p value
0.0017).
(PDF)
Table S12.  Correlations of neuronal characteristics versus
behavioral performance. Correlations of post-mortem (19
weeks) neuronal number (Neur no.), density (Neur dens.) and
regional volume determined through stereology on NeuN-
stained brain sections against behavioral performance
recorded between 15 and 19 weeks of age, presented as
Pearson r values. LMA = locomotor activity in an open field, GS
FL = grip strength of the forelimbs, GS 4L = grip strength of the
fore- and hind limbs, TM CL = swimming T-maze cue learning,
TM CR = swimming T-maze cue reversal, STR = striatum, M1
CTX = primary motor cortex. *Statistically significant after
Bonferroni Correction (adjusted p value 0.0033).
(PDF)
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